(1 - 30 von 53
)
Stimmungswandel für US-Biotechs: Amgen, Biogen – besser als Facebook?...
www.n-tv.de
Im Gegensatz zur Facebook-Aktie tendieren die Papiere der US-Biotechwerte wie Amgen und Biogen seit etlichen Jahren lediglich seitwärts. Sorgt ausgerechnet...
Biogen plans $1B in cost-savings as CEO steps down
www.bizjournals.com
— After more than five years at the helm of embattled Biogen Inc., Michel Vounatsos is stepping down as CEO. › news
NZZ: Biogen: Alzheimer-Flop reisst CEO Michel Vounatsos um - NZZ
› finanzen › alzheimer-flop-bringt-bio...
BRIEF-Biogen CEO Michel Vounatsos' Total Compensation For Was...
www.reuters.com
April 27 (Reuters) - Biogen Inc: * BIOGEN SAYS CEO MICHEL VOUNATSOS' TOTAL COMPENSATION FOR WAS $13.7 MILLION - SEC ...
Michel Vounatsos: Latest News & Videos, Photos about ...economictimes.indiatimes.com › M...
economictimes.indiatimes.com
Michel Vounatsos Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Michel Vounatsos Blogs, Comments and Archive ...
Biogen Names Michel Vounatsos Chief Executive Officer
www.finanznachrichten.de
Industry Veteran to Maintain Company Focus on Neurology and Neurodegeneration; Enhance World-Class R&D Engine Biogen (NASDAQ: BIIB) today announced that …
PerkinElmer Elects Michel Vounatsos to its Board of Directors -...
www.wallstreet-online.de
PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Michel Vounatsos has been ...
Alzheimer: Biogen macht Aducanumab zum Hoffnungsträger
www.handelsblatt.com
... glauben, dass das ein Wendepunkt im Kampf gegen Alzheimer ist“, sagte Biogen-Chef Michel Vounatsos im Gespräch mit dem Handelsblatt.
NZZ: Die Schweizer Erfolgsstory von Biogen | NZZ
Michel Vounatsos, CEO von Biogen. (Bild: PD). Doch die Schweiz ist weiterhin das zweite Standbein des Konzerns, der mit Einnahmen ...
PerkinElmer Elects Michel Vounatsos to its Board of Directors
www.scientifictechnologynews.com
› ...
PerkinElmer (PKI) Reports Election of Michel Vounatsos to Board
www.streetinsider.com
PerkinElmer, Inc. (NYSE: PKI) today announced that Michel Vounatsos has been elected to its board of directors, effective March 1,
PerkinElmer: Michel Vounatsos | Genomeweb
www.genomeweb.com
PerkinElmer has appointed Michel Vounatsos to its board of directors, effective March 1. He is currently CEO of Biogen. Before that, he was at Merck, where he...
Michel Vounatsos graduated from the HEC Paris MBA in HEC Paris...
campus.hec.fr
Michel Vounatsos graduated from the HEC Paris MBA in Michel Vounatsos graduated from the HEC Paris MBA in Posted on July ...
Michel Vounatsos Archives - SABC News - Breaking news ...www.sabcnews.com › tag › michel...
www.sabcnews.com
Biogen scraps Alzheimer's trial, shares skid. 21 March 2019, 2:28 PM. Biogen and partner Eisai Co Ltd are ending two late-stage trials testing an Alzheimer's ...
BIIB Stock Treks Higher Amid News That Biogen CEO Michel ...
investorplace.com
— Drug-making giant Biogen is in the green today after announcing CEO Michel Vounatsos is stepping down from the role. ›
Biogen C.E.O. to Step Down Following Launch of Alzheimer's ...
www.nytimes.com
— Michel Vounatsos, who has led the drug maker for over five years and presided over the approval and launch of the drug, known as Aduhelm, ... › business
Biogen looks for new leadership after Alzheimer's drug fizzles
www.cbsnews.com
— CEO Michel Vounatsos will continue to lead Biogen until a successor is found, the company said Tuesday. Vounatsos has been CEO since › news
What's next for Biogen? Here's what executives are saying
www.pharmavoice.com
— “Pursuit of innovation, however, does not come without setbacks.” Michel Vounatsos. Biogen CEO. Biogen has had its share of setbacks ... › bi...
Beacon Health chief financial officer departs to join Biogen
www.hrmronline.com
Jeffrey Capello, the executive vice president and chief financial officer of Beacon Health Options, has joined US biotech company Biogen in the same position.
Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug
www.detroitnews.com
— ... a health care system that “remains a major bottleneck” in keeping the treatment from patients, CEO Michel Vounatsos said Wednesday. › wellness ›
Biogen Names CEO | Contract Pharma
www.contractpharma.com
— Michel Vounatsos has been appointed chief executive officer of Biogen and member of the board of directors, effective January 6, › ...
Biogen elevates Vounatsos to top seat - PMLiVE
www.pmlive.com
— Biogen has named Michel Vounatsos as its new chief executive, ending a five-month search for a successor to George Scangos. › biogen_...
Biogen news
gcardufficio.it
O) said on Tuesday that chief executive Michel Vounatsos will step down and that the company is pulling back on selling its controversial Alzheimer's drug › biogen-news
Biogen donates $10 million for Cambridge, Somerville STEM programs -...
www.bostonglobe.com
The state’s largest biotech says the effort is aimed at students in grades six through 12.
Biogen news - snapformaps.it
snapformaps.it
1 market in the world—is very good news," Biogen CEO Michel Vounatsos said during the annual J. 00 in a research report issued on Tuesday, Stock Target ... › biogen-news
sortiert nach Relevanz / Datum